Olive Pharmascience Limited - Company Profile

It is a paper public limited company based in Mumbai, Maharashtra, India, established in 2025.
2025 Mumbai, Maharashtra, India Active
Last Updated:
Access Report
About Olive Pharmascience Limited

Olive Pharmascience Limited, a active public limited company, was established on 11 March 2025 in Mumbai, Maharashtra, India. Engaging in manufacturing within the paper sector, it holds CIN: U21002MH2025PLC442746. Registered under ROC Roc Mumbai I. it is unlisted. It has an authorized capital of ₹15.00 Cr and a paid-up capital of ₹0.50 M.

Employing 230 professional, Its leadership includes Kamlesh Shah (Director), Jigar Kamlesh Shah (Director), Hardik Kamlesh Shah (Director). It is based at 203-B, Godrej Coliseum, Somaiya Hospital Road, Mumbai, Maharashtra, 400022.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U21002MH2025PLC442746

  • Registration Number

    442746

  • Incorporation Date

    11 March 2025

  • Authorized Capital

    ₹15.00 Cr

  • Paid-Up Capital

    ₹0.50 M

  • ROC Code

    Roc Mumbai I

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 15.00 Cr
  • Paid Up Capital ₹ 0.50 M
  • Company Age 11 Months 27 Days
Company report

Olive Pharmascience Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Olive Pharmascience Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Olive Pharmascience Limited?
Current Directors
Name Designation Appointment Date Status
Kamlesh Shah Director 11 Mar 2025 Current
Jigar Kamlesh Shah Director 11 Mar 2025 Current
Hardik Kamlesh Shah Director 11 Mar 2025 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Olive Pharmascience.

Enhance accessibility to Olive Pharmascience's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Olive Pharmascience revenue growth over time
Olive Pharmascience profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Olive Pharmascience?

Unlock access to Olive Pharmascience's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Olive Pharmascience?

Olive Pharmascience has a workforce of 230 employees as of Feb 23, 2026. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Olive Pharmascience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Olive Pharmascience's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Olive Pharmascience
Recent Activity within the Organization
  • Director Appointment

    Progress on Kamlesh Shah was appointed as a Director was appointed as a Director on 11 Mar 2025 & has been associated with this company since 11 months 27 days . was documented.

  • Director Appointment

    Jigar Kamlesh Shah was appointed as a Director was appointed as a Director on 11 Mar 2025 & has been associated with this company since 11 months 27 days . was recorded as a recent event.

  • Director Appointment

    Hardik Kamlesh Shah was appointed as a Director was appointed as a Director on 11 Mar 2025 & has been associated with this company since 11 months 27 days . was recorded as a recent event.

  • Company Incorporation

    Progress on Olive Pharmascience Limited was registered on 11 Mar 2025 with Roc Mumbai I & aged 11 months 27 days as per MCA records. was documented.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Olive Pharmascience Limited?

The CIN of Olive Pharmascience Limited is U21002MH2025PLC442746.

Where is Olive Pharmascience Limited headquartered?

Olive Pharmascience Limited is headquartered at 203-B, Godrej Coliseum, Somaiya Hospital Road, Mumbai, Maharashtra, 400022.

When was Olive Pharmascience Limited incorporated?

Olive Pharmascience Limited was incorporated on 11 March 2025.

Who are the current directors of Olive Pharmascience Limited?

The current directors of Olive Pharmascience Limited are

What is the primary industry of Olive Pharmascience Limited?

The primary industry of Olive Pharmascience Limited is Paper.

Is Olive Pharmascience Limited a listed company?

Olive Pharmascience Limited is unlisted.

What is the capital structure of Olive Pharmascience Limited?

The authorized capital of Olive Pharmascience Limited is ₹15.00 Cr, and the paid-up capital is ₹0.50 M.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available